Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00028080
DRKS00028080
Recruiting
N/A

Contrast-enhanced ultrasound (CEUS) for assessment of perfusion patterns of musculoskeletal tumors - CEUS TUMOR

Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie0 sites300 target enrollmentFebruary 14, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsD48.9Neoplasm of uncertain or unknown behaviour, unspecified

Overview

Phase
N/A
Intervention
Not specified
Conditions
D48.9
Sponsor
Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie
Enrollment
300
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 14, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie

Eligibility Criteria

Inclusion Criteria

  • •Adult patients with a musculoskeletal tumor who are being treated surgically at the Heidelberg University Hospital are included in the study.

Exclusion Criteria

  • •Age under 18 years
  • •Inability to consent
  • •Known intolerance to SonoVue® or other ultrasound contrast media.
  • •Severe heart failure (NYHA III and IV), right\-to\-left shunt in the heart, uncontrollable high blood pressure.
  • •Severe pulmonary disease, particularly severe obstructive pulmonary disease, ARDS and severe pulmonary arterial hypertension.
  • •Myocardial infarction within the last 14 days.
  • •Disorders of the galactose metabolism (galactosemia).
  • •Pregnancy and breast feeding period.
  • •Lack of informed consent or refusal to participate.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
Contrast-enhanced ultrasound (CEUS) to assess perfusion in suspected joint infection after arthroplasty joint replacementT84.0Mechanical complication of internal joint prosthesis
DRKS00028083Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie100
Completed
N/A
Contrast-enhanced Ultrasound (CEUS) for determining muscular Perfusion after oral intake of L-Citrulline, L-Arginine, and galloylated epicatechines.Examination of different sport supplement ingredients for their potency of vasodilation in skeletal muscle.
DRKS00016972niversität Heidelberg, Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie30
Recruiting
N/A
sefulness of contrast-enhanced ultrasound (CEUS) in Crohn’s disease pediatric patientsDiseases of the digestive system
KCT0005685Yonsei University Health System, Severance Hospital20
Active, Not Recruiting
Phase 1
Study of placental vascularization using contrast ultrasoundFetal growth restrictionMedDRA version: 20.0Level: PTClassification code: 10070531Term: Foetal growth restriction Class: 100000004868Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
CTIS2023-506936-34-00CHRU De Nancy30
Recruiting
N/A
Quantification of Contrast Enhanced Ultrasound (CEUS) in the detection of Prostate cancer.Prostate adenocarcinomaProstate cancer10038364
NL-OMON36092Academisch Medisch Centrum560